Skip to main content
Subscribe
  • Login
  • My Account
  • Logout
  • Register For Free
  • Subscribe
  • News
    • Current News
    • Providers
    • Insurance
    • Government
    • Finance
    • Technology
    • Safety & Quality
    • Digital Health
    • Transformation
    • ESG
    • People
    • Regional News
    • Digital Edition (Web Version)
    • Patients
    • Operations
    • Care Delivery
    • Payment
    • Midwest
    • Northeast
    • South
    • West
  • Blogs
    • AI
    • Deals
    • Layoff Tracker
    • HLTH 2024
    • Sponsored Content: Vital Signs Blog
  • Opinion
    • Letters
    • From the Editor
  • Events & Awards
    • Awards
    • Conferences
    • Galas
    • Virtual Briefings
    • Webinars
    • Nominate/Eligibility
    • 100 Most Influential People
    • 50 Most Influential Clinical Executives
    • 40 Under 40
    • Best Places to Work in Healthcare
    • Healthcare Marketing Impact Awards
    • Innovators Awards
    • Diversity Leaders
    • Leading Women
    • Best in Business Awards
    • The 2030 Playbook Conference
    • Innovations in Patient Experience
    • Leading Women Conference & Awards Luncheon
    • Leadership Summit
    • Workforce Summit
    • Best Places to Work Awards Gala
    • Diversity Leaders Gala
    • - Looking Ahead to 2025
    • - Financial Growth
    • - Hospital of the Future
    • - Value Based Care
    • - Looking Ahead to 2026
  • Multimedia
    • Podcast - Beyond the Byline
    • Sponsored Podcast - Healthcare Insider
    • Sponsored Video Series - One on One
    • Sponsored Video Series - Checking In with Dan Peres
  • Data & Insights
    • Data & Insights Home
    • Hospital Financials
    • Staffing & Compensation
    • Quality & Safety
    • Mergers & Acquisitions
    • Skilled Nursing Facilities
    • Data Archive
    • Resource Guide: By the Numbers
    • Surveys
    • Data Points
  • Newsletters
  • MORE+
    • Contact Us
    • Advertise
    • Media Kit
    • Jobs
    • People on the Move
    • Reprints & Licensing
    • Sponsored Content
MENU
Breadcrumb
  1. Home
  2. Government
October 26, 2018 12:00 AM

5 questions on Trump's newest drug-pricing plan

Susannah Luthi
  • Tweet
  • Share
  • Share
  • Email
  • More
    Reprints Print
    Getty Images/Glowimages RF

    President Donald Trump on Thursday made his biggest move yet to curb soaring drug prices, proposing a mandatory Medicare Part B pay model that would change drug rates and how physicians are paid for those medications. It has analysts, industry members, advocates and politicians buzzing with praise and criticism for the plan.

    But it also has everyone looking for more details. Here are the top five questions swirling about the Trump administration's latest move.

    1. Will the international benchmark actually come to fruition?

    Skeptics doubt the Trump administration will follow through with the splashiest part of the proposal: tying Medicare Part B drug prices to foreign prices for the same drugs, which are often significantly lower. The proposal flies far afield of the Trump administration's usual free market rhetoric and reliance on foreign governments' own price controls.

    "The international comparison ties in well with President Trump's 'America First' agenda and political messaging, and in this instance, we believe CMS is using international pricing as a negotiating tactic with manufacturers," analysts from Height Capital Markets concluded.

    2. Could HHS stop Big Pharma from gaming the new system?

    Even if the CMS ties its drug rates to other countries' price tags, drugmakers could strike deals to hike foreign list prices and apply rebates that lower the ultimate cost of the drug internationally. HHS Secretary Alex Azar told an audience at the Brookings Institution in Washington on Friday that the agency has data sources to show net pricing information, which could be leveraged to stop those workarounds.

    Skeptics don't think this is enough.

    "If 15 countries are all trying to game the system in the same way, it's basically impossible to administratively police it," said Benedic Ippolito of the center-right American Enterprise Institute.

    3. Could the plan look like the Obama administration's failed Part B demo?

    Absolutely not, Azar said. The HHS secretary argued on Friday that the Obama-era proposal didn't take aim at the underlying sales price of a drug.

    The Obama administration proposed a sharp cut to providers' margins—average sales price plus 6%, or 4.3% under the Medicare sequester—for the drugs they buy and administer for patients.

    The Trump administration is instead proposing a flat administrative fee that isn't based on an individual drug's price. It will be calculated based on a drug's class. Azar emphasized that this proposal must be paired with the international benchmark plan.

    "Conceptually, what it's trying to do is similar" to the Obama demo, said Matt Fiedler of the Brookings Institution, who worked on the demo in the Obama administration. "If your goal is to weaken the incentive for providers to choose high-priced drugs, the effect is quite similar."

    4. Will providers take a hit?

    "We will make this work for physicians and hospitals," Azar told the Brookings audience on Friday as he promised that their overall compensation would remain stable.

    The HHS secretary added that disentangling provider compensation from drug prices is key. He wants to work with provider groups and find how to make the idea work logistically. Provider groups banded together to help sink the Obama administration's Part B demonstration.

    Critics and skeptics of the overall plan agree that the administrative side of Medicare Part B needs significant cleanup and that the incentives are bad for patients' pocketbooks.

    5. Is this a step toward direct Medicare drug negotiation?

    House Democrats have signaled they want to work with Trump on drug pricing. But many of them want Medicare to negotiate prices—an idea Azar has emphatically rejected.

    Azar said the international benchmark keeps the pharmaceutical industry in the driver's seat because it's up to manufacturers to negotiate with the foreign governments.

    But the idea of House Democrats cutting deals with the Trump administration over drug pricing has the drug industry worried, and this proposal is the first signal that tighter price controls are on the table.

    Letter
    to the
    Editor

    Send us a letter

    Have an opinion about this story? Click here to submit a Letter to the Editor, and we may publish it in print.

    Recommended for You
    Legal-government-0225
    HHS lawsuit by Democratic AGs aims to stop restructuring, layoffs
    GettyImages-654573744.jpg
    Federal watchdog to retract medical debt collection opinion
    Most Popular
    1
    UnitedHealth under criminal investigation for Medicare fraud: WSJ
    2
    States, providers face brunt of GOP Medicaid cuts plan
    3
    UnitedHealth Group to cut Medicare drug plan commissions
    4
    Federal dementia pilot has rocky rollout for some providers
    5
    'Legendary' Hemsley takes over at UnitedHealth amid rough seas
    Sponsored Content
    Modern Healthcare Alert: Sign up for this breaking news email to be kept in the loop as urgent healthcare business news unfolds.
    Get Newsletters

    Sign up for enewsletters and alerts to receive breaking news and in-depth coverage of healthcare events and trends, as they happen, right to your inbox.

    Subscribe Today
    MH Magazine Cover

    MH magazine offers content that sheds light on healthcare leaders’ complex choices and touch points—from strategy, governance, leadership development and finance to operations, clinical care, and marketing.

    Subscribe
    Connect with Us
    • LinkedIn
    • Twitter
    • Facebook
    • RSS

    Our Mission

    Modern Healthcare empowers industry leaders to succeed by providing unbiased reporting of the news, insights, analysis and data.

    Contact Us

    (877) 812-1581

    Email us

     

    Resources
    • Contact Us
    • Help Center
    • Advertise with Us
    • Ad Choices
    • Sitemap
    Editorial Dept
    • Submission Guidelines
    • Code of Ethics
    • Awards
    • About Us
    Legal
    • Terms and Conditions
    • Privacy Policy
    • Privacy Request
    Modern Healthcare
    Copyright © 1996-2025. Crain Communications, Inc. All Rights Reserved.
    • News
      • Current News
      • Providers
      • Insurance
      • Government
      • Finance
      • Technology
      • Safety & Quality
      • Digital Health
      • Transformation
        • Patients
        • Operations
        • Care Delivery
        • Payment
      • ESG
      • People
      • Regional News
        • Midwest
        • Northeast
        • South
        • West
      • Digital Edition (Web Version)
    • Blogs
      • AI
      • Deals
      • Layoff Tracker
      • HLTH 2024
      • Sponsored Content: Vital Signs Blog
    • Opinion
      • Letters
      • From the Editor
    • Events & Awards
      • Awards
        • Nominate/Eligibility
        • 100 Most Influential People
        • 50 Most Influential Clinical Executives
        • 40 Under 40
        • Best Places to Work in Healthcare
        • Healthcare Marketing Impact Awards
        • Innovators Awards
        • Diversity Leaders
        • Leading Women
        • Best in Business Awards
      • Conferences
        • The 2030 Playbook Conference
        • Innovations in Patient Experience
        • Leading Women Conference & Awards Luncheon
        • Leadership Summit
        • Workforce Summit
      • Galas
        • Best Places to Work Awards Gala
        • Diversity Leaders Gala
      • Virtual Briefings
        • - Looking Ahead to 2025
        • - Financial Growth
        • - Hospital of the Future
        • - Value Based Care
        • - Looking Ahead to 2026
      • Webinars
    • Multimedia
      • Podcast - Beyond the Byline
      • Sponsored Podcast - Healthcare Insider
      • Sponsored Video Series - One on One
      • Sponsored Video Series - Checking In with Dan Peres
    • Data & Insights
      • Data & Insights Home
      • Hospital Financials
      • Staffing & Compensation
      • Quality & Safety
      • Mergers & Acquisitions
      • Skilled Nursing Facilities
      • Data Archive
      • Resource Guide: By the Numbers
      • Surveys
      • Data Points
    • Newsletters
    • MORE+
      • Contact Us
      • Advertise
      • Media Kit
      • Jobs
      • People on the Move
      • Reprints & Licensing
      • Sponsored Content